The structural chemistry of the phytocannabinoid family: eleven classes, the C1-to-C8 side-chain series and its structure-activity relationship, ring arrangement and pharmacology, isomerism and the analytics it forces, plant biosynthesis, decarboxylation arithmetic, the transformation matrix, and the pharmacological line between a phytocannabinoid and a synthetic cannabimimetic.
10 pages · 41 citations (4 without a resolved identifier, marked on the page) · updated 2026-09-27
What this section is, and what it is not
Education and harm reduction. Not medical, legal or financial advice. Every factual claim carries a source; contested and single-source claims are marked as such on the page.
The boundary. This section teaches separation, purification, formulation, dosing arithmetic and analytical chemistry with real parameters, because withholding that detail from someone who will proceed anyway is the harm this library exists to prevent. It does not publish preparative routes for converting one cannabinoid into a more intoxicating one; those are described structurally and cited to the literature, without procedures.
Pages
Phytocannabinoids are conventionally sorted into eleven structural types plus a miscellaneous group. A type is a carbon skeleton and a ring arrangement, not a pharmacological category — which is why one type contains both an intoxicant and a non-intoxicant, and why the class table is the right index for the whole family.
5 sections · cannabinoid
The alkyl side chain is the single most consequential structural variable in the cannabinoid family. Homologues from one to eight carbons occur naturally, CB1 affinity rises with chain length to an optimum around seven or eight carbons and then falls away, and the propyl homologue reverses sign and behaves as an antagonist. This page gives the series, the real affinity numbers, and an explicit accounting of which potency multipliers in circulation could not be sourced.
9 sections · cannabinoid
Whether the resorcinol ring is closed onto the terpene unit, and how, is what separates a non-intoxicating cannabinoid from an intoxicating one. This page works through the seven ring arrangements in the family and then makes the analytical point that follows from them: CBD and Δ9-THC share a molecular formula and an exact mass, so no mass measurement can tell them apart.
5 sections · cannabinoid
Within the THC skeleton the same atoms can be arranged in many ways: the alkene can sit in several positions, the two stereocentres give four configurations, and the ring can be opened into iso-THC forms. All of these share one exact mass, so identification rests entirely on retention time against an authentic standard — and a standard that does not exist cannot identify anything.
4 sections · cannabinoid
Two independent metabolic routes converge in the glandular trichome to make cannabigerolic acid, and three FAD-dependent oxidocyclases then route it to the THC, CBD and CBC acid series. The allele ratio at a single genetic locus determines which of them dominates, which is why hemp and marijuana are a genetic distinction and not only a legal one.
7 sections · enzyme
THCA becomes THC by losing carbon dioxide from its aromatic carboxylic acid. The mass ratio of the two molecules is 0.877, which is where the total-THC formula comes from and why it is a theoretical ceiling rather than a yield. THCA is not intoxicating in the way THC is, and it is nonetheless the analyte that decides legal status.
5 sections · cannabinoid
A map of how cannabinoid structures relate to one another by conversion, in two clearly separated groups: the passive degradations that a processor manages in storage and a chemist reads off a stability study, and the deliberate chemical conversions described here as structural changes with citations only. Nothing on this page tells anyone how to do anything.
6 sections · cannabinoid
John W. Huffman made hundreds of cannabinoid receptor ligands as pharmacological tools. The indole-based ones became K2 and Spice, and they differ from phytocannabinoids in the way that matters most: they are full agonists at high affinity, where Δ9-THC is a partial agonist. A partial agonist has a ceiling and a full agonist does not, which is the whole of the toxicological difference.
6 sections · safety
Roger Adams at Illinois, working with Minnesota wild hemp between 1940 and 1942, isolated CBD, established the structure of CBN, reported the acid conversion of CBD to THC, and named the THC isomers by optical rotation because the double-bond positions could not yet be assigned. Two numbering conventions survive from that era, which is why the same molecule appears as Δ9-THC and Δ1-THC in papers of different decades.
5 sections · tool
Most of the cannabinoid family has never been looked at. The combinatorial space runs to thousands of structures, a few hundred have been detected and a few dozen pharmacologically characterised. Every one of the resulting research questions runs through the same constraint: without an authentic reference standard a compound cannot be identified or quantified, so reference-standard work is the rate-limiting step for the whole field.
8 sections · cannabinoid